Bilgilendirme: Kurulum ve veri kapsamındaki çalışmalar devam etmektedir. Göstereceğiniz anlayış için teşekkür ederiz.

Publication:
Assessment of Serological Data of Herpes Simplex Virus Type 1 and 2 Infections in Samsun, Turkey, 2012-2016

dc.authorscopusid23982772400
dc.authorscopusid56689626000
dc.authorscopusid24280435800
dc.authorscopusid57220350344
dc.authorscopusid15062055100
dc.contributor.authorArtiran Iǧde, F.A.
dc.contributor.authorTaskin, M.H.
dc.contributor.authorİğde, M.
dc.contributor.authorErdem, F.
dc.contributor.authorYazici, Z.
dc.date.accessioned2020-06-21T13:18:28Z
dc.date.available2020-06-21T13:18:28Z
dc.date.issued2017
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Artiran Iǧde] Füsun Arttiran, Department of Family Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Taskin] Mehmet Hakan,; [İĞde] Mahir, Department of Pediatrics Allergic Diseases, Maternity and Child Care Hospital, Samsun, Turkey; [Erdem] Funda, Department of Virology, Public Health Laboratory, Samsun, Turkey; [Yazici] Zafer, Department of Virology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractHerpes simplex virus type 1 and 2 (HSV-1 and HSV-2) are worldwide the most common human pathogens with a lifelong latency. HSV-1 more commonly causes orofacial infection while HSV-2 typically genital infection in both males and females of all age groups. The aim of this study was to determine the prevalence of IgG and IgM against HSV-1 and HSV-2 among various age groups in Samsun, Turkey between 2012 and 2016.Overall the prevalence of IgG and IgM for HSV-1 was 89% and 4%, respectively, and that against HSV-2 92% and 6%, respectively. The prevalence of IgG against HSV-1 and -2 was 69-94% for all age groups, and that of IgM for HSV-1 and -2 4-8% for ages >1 to 55 years, with no IgM detected for ages >55 years. Interactions with other sexually transmitted diseases and an increasing prevalence of HSVs have made these infections a major public health concern worldwide in the past few decades. Hence, early diagnosis and initiation of therapy are important for the management of these infections. © 2017, SEAMEO TROPMED Network. All rights reserved.en_US
dc.identifier.endpage1005en_US
dc.identifier.issn0125-1562
dc.identifier.issn2697-5718
dc.identifier.issue5en_US
dc.identifier.scopus2-s2.0-85042320704
dc.identifier.scopusqualityQ4
dc.identifier.startpage999en_US
dc.identifier.volume48en_US
dc.identifier.wosWOS:000414275800006
dc.identifier.wosqualityQ4
dc.language.isoenen_US
dc.publisherSEAMEO TROPMED Networken_US
dc.relation.ispartofSoutheast Asian Journal of Tropical Medicine and Public Healthen_US
dc.relation.journalSoutheast Asian Journal of Tropical Medicine and Public Healthen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHSV-1en_US
dc.subjectHSV-2en_US
dc.subjectIgGen_US
dc.subjectIgMen_US
dc.subjectSeropositivityen_US
dc.titleAssessment of Serological Data of Herpes Simplex Virus Type 1 and 2 Infections in Samsun, Turkey, 2012-2016en_US
dc.typeArticleen_US
dspace.entity.typePublication

Files